Visit Foot Blog

EU Agency Recommends Restricted Use for Piroxicam

Posted on July 05, 2007

MNT -The European Medicines Agency (EMEA) has recommended restrictions on the use of piroxicam-containing medicinal products because of the risk of gastrointestinal side effects and serious skin reactions. The Agency s Committee for Medicinal Products for Human Use (CHMP) concluded that piroxicam should no longer be used for treatment of short-term painful and inflammatory conditions. Piroxicam can still be prescribed for the symptomatic relief of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. However it should not be the first choice of non-steroidal anti-inflammatory dru...

Original article link


ankylosing spondylitis , arthritis , osteoarthritis , rheumatoid arthritis , skin